Go Naka
Impact in
-
- Lung Cancer Treatments and Mutations
- Respiratory and Cough-Related Research
Papers in
-
- Lung Cancer Treatments and Mutations 16
- Lung Cancer Diagnosis and Treatment 4
- Medical Imaging and Pathology Studies 3
- Oncology 9
- Lung Cancer Research Studies 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Haruhito Sugiyama (24 shared papers)Yuichiro Takeda (26 shared papers)Masayuki Hojo (13 shared papers)Motoyasu Iikura (13 shared papers)Shinyu Izumi (14 shared papers)Satoru Ishii (11 shared papers)Jin Takasaki (7 shared papers)Nobuyuki Kobayashi (5 shared papers)
- Journals
- Japanese Journal of Clinical Oncology (5 papers)BMC Cancer (2 papers)Medicine (1 paper)BMJ Open (1 paper)PLoS ONE (1 paper)
- Partner nations
- JapanUnited StatesSpain
In The Last Decade
Go Naka
39 papers receiving 283 citations
Peers
Comparison fields: 5 of 60
- Pulmonary and Respiratory Medicine 100
- Microbiology 2
- Physiology 46
- Oncology 47
- Epidemiology 52
Countries citing papers authored by Go Naka
This map shows the geographic impact of Go Naka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Go Naka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Go Naka more than expected).
Fields of papers citing papers by Go Naka
This network shows the impact of papers produced by Go Naka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Go Naka. The network helps show where Go Naka may publish in the future.
Co-authors
The 25 scholars most cited alongside Go Naka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 84 | |
| 2 | 2007 | 23 | |
| 3 | 2014 | 21 | |
| 4 | 2019 | 14 | |
| 5 | 2020 | 11 | |
| 6 | 2019 | 10 | |
| 7 | 2020 | 9 | |
| 8 | The pharmacokinetics and long-term therapeutic effects of gefitinib in patients with lung adenocarcinoma harboring the epidermal growth factor receptor(EGFR)mutation. | 2012 | 9 |
| 9 | 2019 | 8 | |
| 10 | A case of endobronchial NUT midline carcinoma with intraluminal growth. | 2015 | 8 |
| 11 | 2016 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2015 | 7 | |
| 14 | 2005 | 7 | |
| 15 | 2016 | 6 | |
| 16 | 2022 | 5 | |
| 17 | 2024 | 5 | |
| 18 | 2020 | 5 | |
| 19 | 2006 | 5 | |
| 20 | 2020 | 5 |
About Go Naka
Go Naka is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Epidemiology, having authored 41 papers that have together received 291 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (4 papers), Protein Degradation and Inhibitors (3 papers), Lung Cancer Research Studies (3 papers), Medical Imaging and Pathology Studies (3 papers), Ubiquitin and proteasome pathways (2 papers), IgG4-Related and Inflammatory Diseases (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (100 citations), Microbiology (2 citations), Physiology (46 citations), Oncology (47 citations) and Epidemiology (52 citations). Go Naka has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Haruhito Sugiyama, Yuichiro Takeda, Masayuki Hojo, Motoyasu Iikura, Shinyu Izumi, Satoru Ishii, Jin Takasaki, Nobuyuki Kobayashi, Susumu Nakae and Shoki Ro. Their work appears in journals such as Japanese Journal of Clinical Oncology, BMC Cancer, Medicine, BMJ Open and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.